The understanding of irritable bowel syndrome (IBS) has undergone a rapid evolution with
scientific advancement. IBS is a common functional bowel disorder that generates a …

METHODS We have conducted a series of systematic reviews on the efficacy of therapy in
IBS and CIC. There have been several systematic reviews of therapy for IBS and CIC …

Background: IBS affects 5–11% of the population of most countries. Prevalence peaks in the
third and fourth decades, with a female predominance. Aim: To provide a guide for the …

Introduction Chronic constipation is highly prevalent, affecting between 10% and 15% of the
population. The Rome IV criteria categorizes disorders of chronic constipation into four …

Irritable bowel syndrome (IBS) is the most prevalent of the functional gastrointestinal
disorders (FGIDs). Current estimates are that IBS affects up to 10–12% of adults in North …

Background Chronic constipation is a common, heterogeneous disorder with multiple
symptoms and pathophysiological mechanisms. Patients are often referred to a …

Aim: To determine the prevalence, symptom pattern and impact of the irritable bowel
syndrome, across eight European countries, using a standardized methodology. Methods: A …

Irritable bowel syndrome (IBS) is a highly prevalent functional bowel disorder routinely
encountered by healthcare providers. Although not life-threatening, this chronic disorder …

Chronic constipation is a common, persistent condition affecting many patients worldwide,
presenting significant economic burden and resulting in substantial healthcare utilization. In …

Background Chronic abdominal pain, bloating, constipation, diarrhea, and stool irregularity
are common symptoms in primary care and gastroenterology. A routine diagnostic …